Found 5 matching trials
A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease
PHASE2The primary objective of the study was to investigate long-term safety of r...
Location
MGG Group, Inc.Chevy Chase Clinical Research /ID# 155068
Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.
PHASE2This study is a proof of concept, multi-center, randomized, double-blind, p...
Location
Multiple Locations
A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
PHASE2The primary objective of this study is to assess the safety and efficacy of...
Location
Burke Pharmaceutical Research /ID# 211671
Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis
PHASE2The primary objective of Study M16-009 was to investigate the safety of ris...
Location
Multiple Locations
BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)
PHASE2The overall purpose of the trial is to assess the clinical efficacy of thre...
Location
Multiple Locations